GoodRx
GoodRx agreed to pay a $1.5 million fine under the proposed order, but it admitted no wrongdoing.
GoodRx will continue to own and operate its telehealth platform. The deal is expected to close at the end of November.
The company also announced a partnership with pharma giant Biogen that allows providers to submit enrollment forms for its multiple sclerosis drug Vumerity through the new platform.
Curative is shifting from COVID-19 testing to launching a new health plan as testing needs decrease.
According to an SEC filing, the cuts will primarily affect its technology-focused and marketing groups.
This news comes just after GoodRx announced it had missed its Q4 earnings expectations.
Wheel providers will now be able to give their patients a GoodRx coupon for their medications.
Also: Amwell misses revenue expectations and Babylon Health grows 371% year-over-year.
The new tool gives users in-depth, vetted information based on medical research.
The company is now facing even more competition from retail giant Amazon.